Metabasis Reports Disappointments On Two Pipeline Candidates
Phase IIb trial of a type 2 diabetes candidate fails to show efficacy over metformin, and Schering-Plough also returns rights to hepatitis b candidate pradefovir.
Phase IIb trial of a type 2 diabetes candidate fails to show efficacy over metformin, and Schering-Plough also returns rights to hepatitis b candidate pradefovir.